Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00243204 | Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00290017 | Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 |
| clinicaltrials |
| NCT00126893 | Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia | terminated | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00255333 | INNO-105 in Patients With Solid Tumors | terminated | Phase 1 | 24 | Innovive PharmaceuticalsINDUSTRY | 1 | May 14, 2007 | clinicaltrials |
| NCT00080028 | Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | terminated | Phase 1 | 18 | Pharmacyclics LLC.INDUSTRY | 1 | May 8, 2007 | clinicaltrials |
| NCT00143884 | Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 23, 2007 | clinicaltrials |
| NCT00225056 | Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma | terminated | Phase 2 | 43 | Oncology Specialties, AlabamaOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00229567 | Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function | terminated | N/A | 60 | University of SaskatchewanOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00106262 | Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer | terminated | Phase 2 | 38 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Apr 18, 2007 | clinicaltrials |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | terminated | Phase 2 | 24 | Swedish Medical CenterOTHER | 1 | Apr 5, 2007 | clinicaltrials |
| NCT00195247 | Study Evaluating TTI-237 in Advanced Malignant Solid Tumors | terminated | Phase 1 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00195325 | Study Evaluating TTI-237 in Advanced Malignant Solid Tumors. | terminated | Phase 1 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00099281 | DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer | terminated | Phase 3 | 700 | YM BioSciencesINDUSTRY | 1 | Feb 28, 2007 | clinicaltrials |
| NCT00287482 | Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. | terminated | N/A | 20 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Feb 12, 2007 | clinicaltrials |
| NCT00133302 | Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) | terminated | Phase 3 | 450 | Japan Clinical Oncology GroupOTHER | 1 | Jan 18, 2007 | clinicaltrials |
| NCT00232128 | Protocol for Radiofrequency Ablation of Pulmonary Neoplasms | terminated | N/A | — | Oncology Specialties, AlabamaOTHER | 1 | Jan 12, 2007 | clinicaltrials |
| NCT00420862 | The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography | terminated | Phase 3 | 2,400 | Istituto Clinico HumanitasOTHER | 1 | Jan 11, 2007 | clinicaltrials |
| NCT00123877 | Study of GPX-100 in the Treatment of Metastatic Breast Cancer | terminated | Phase 2 | 40 | Gem PharmaceuticalsINDUSTRY | 2 | Jan 9, 2007 | clinicaltrials |
| NCT00088647 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | terminated | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 8, 2006 | clinicaltrials |
| NCT00277836 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | terminated | Phase 1 | 60 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 8, 2006 | clinicaltrials |
| NCT00152594 | Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia | terminated | Phase 3 | 150 | University of CologneOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00210002 | Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced | terminated | Phase 2 | 55 | Institut Claudius RegaudOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00210028 | Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 40 | Institut Claudius RegaudOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00132756 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 30 | Morton Plant Mease Health CareOTHER | 1 | Nov 8, 2006 | clinicaltrials |
| NCT00104286 | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors | terminated | Phase 1 / Phase 2 | 50 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00129948 | Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) | terminated | Phase 2 | 211 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00395655 | Hydralazine and Valproate Added to Chemotherapy for Breast Cancer | terminated | Phase 2 | 43 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00040170 | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer | terminated | Phase 2 | 50 | TransgeneINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00224692 | Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine | terminated | Phase 3 | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00241267 | Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | terminated | — | 20 | University Hospital, ToursOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer | terminated | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Sep 15, 2006 | clinicaltrials |
| NCT00194935 | Weekly Topotecan Therapy in Patients With Ovarian Cancer | terminated | Phase 2 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00057343 | Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma | terminated | Phase 3 | 400 | BiogenINDUSTRY | 1 | Sep 12, 2006 | clinicaltrials |
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | terminated | Phase 2 | 27 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180830 | Glivec Phase II Pediatric Study | terminated | Phase 2 | 36 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Sep 11, 2006 | clinicaltrials |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | terminated | Phase 2 | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180960 | Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia | terminated | Phase 2 | 100 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00355212 | Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma | terminated | Phase 3 | 240 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00051688 | Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00337506 | Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma | terminated | Phase 2 | 50 | Nantes University HospitalOTHER | 1 | Jun 16, 2006 | clinicaltrials |
| NCT00114946 | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer | terminated | Phase 4 | 800 | Genentech, Inc.INDUSTRY | 0 | May 29, 2006 | clinicaltrials |
| NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | terminated | Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Apr 21, 2006 | clinicaltrials |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma | terminated | Phase 1 / Phase 2 | 60 | Celgene CorporationINDUSTRY | 1 | Apr 12, 2006 | clinicaltrials |
| NCT00309517 | Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C | terminated | Phase 3 | 700 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00303407 | Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care | terminated | — | — | University Hospital, GenevaOTHER | 1 | Mar 16, 2006 | clinicaltrials |
| NCT00101621 | Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain | terminated | Phase 2 | 24 | MetaPhore PharmaceuticalsINDUSTRY | 0 | Feb 9, 2006 | clinicaltrials |
| NCT00100737 | Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL) | terminated | Phase 2 | 300 | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00103428 | Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 69 | Cell GenesysINDUSTRY | 1 | Feb 2, 2006 | clinicaltrials |
| NCT00151645 | Efficacy of Activated Lymphocytes in Renal Cell Carcinoma. | terminated | Phase 2 | 36 | Rennes University HospitalOTHER | 1 | Jan 2, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Jun 8, 2007source: clinicaltrials